Phase II trial of sunitinib malate in patients with temozolomide refractory recurrent high-grade glioma

被引：0
|
作者：
Neyns, B. [1 ,2 ]
Chaskis, C. [1 ,2 ]
Dujardin, M. [1 ,2 ]
Everaert, H. [1 ,2 ]
Sadones, J. [1 ,2 ]
Nupponen, N. N. [1 ,2 ]
Michotte, A. [1 ,2 ]
机构：
[1] UZ Brussel, Brussels, Belgium
[2] Univ Helsinki, Helsinki, Finland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2038
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase II study of sunitinib malate in patients with recurrent high-grade glioma
    Neyns, B.
    Sadones, J.
    Chaskis, C.
    Dujardin, M.
    Everaert, H.
    Lv, S.
    Duerinck, J.
    Tynninen, O.
    Nupponen, N.
    Michotte, A.
    De Greve, J.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2011, 103 (03) : 491 - 501
  • [2] Phase II study of sunitinib malate in patients with recurrent high-grade glioma
    B. Neyns
    J. Sadones
    C. Chaskis
    M. Dujardin
    H. Everaert
    S. Lv
    J. Duerinck
    O. Tynninen
    N. Nupponen
    A. Michotte
    J. De Greve
    [J]. Journal of Neuro-Oncology, 2011, 103 : 491 - 501
  • [3] A phase II trial of sunitinib in patients with recurrent high-grade glioma
    Chaskis, C.
    Sadones, J.
    Michotte, A.
    Dujardin, M.
    Everaert, H.
    Neyns, B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] SUNITINIB MALATE AS A SINGLE AGENT OR COMBINED WITH LOMUSTINE (CCNU) IN PATIENTS WITH RECURRENT, TEMOZOLOMIDE REFRACTORY HIGH-GRADE GLIOMA
    Neyns, B.
    Lv, S.
    Chaskis, C.
    Sadones, J.
    Dujardin, M.
    Everaert, H.
    Duerinck, J.
    Nupponen, N.
    Michotte, A.
    De Greve, J.
    [J]. NEURO-ONCOLOGY, 2010, 12 : 16 - 16
  • [5] Phase II trial of temozolomide in children with recurrent high-grade glioma
    Ruggiero, A.
    Cefalo, G.
    Garre, M. L.
    Massimino, M.
    Colosimo, C.
    Attina, G.
    Lazzareschi, I.
    Maurizi, P.
    Ridola, V.
    Mazzarella, G.
    Caldarelli, M.
    Di Rocco, C.
    Madon, E.
    Abate, M. E.
    Clerico, A.
    Sandri, A.
    Riccardi, R.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2006, 77 (01) : 89 - 94
  • [6] Phase II trial of temozolomide in children with recurrent high-grade glioma
    A. Ruggiero
    G. Cefalo
    M.L. Garré
    M. Massimino
    C. Colosimo
    G. Attinà
    I. Lazzareschi
    P. Maurizi
    V. Ridola
    G. Mazzarella
    M. Caldarelli
    C. Di Rocco
    E. Madon
    M.E. Abate
    A. Clerico
    A. Sandri
    R. Riccardi
    [J]. Journal of Neuro-Oncology, 2006, 77 : 89 - 94
  • [7] Phase II trial of sunitinib malate and lomustine in patients with temozolomide refractory recurrent low-grade and anaplastic gliomas.
    Duerinck, Johnny
    Du Four, Stephanie
    Van Binst, An
    Everaert, Hendrik
    Michotte, Alex
    D'haens, Jean
    Neyns, Bart
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma
    Bower, M
    Newlands, ES
    Bleehen, NM
    Brada, M
    Begent, RJH
    Calvert, H
    Colquhoun, I
    Lewis, P
    Brampton, MH
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (06) : 484 - 488
  • [9] Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma
    M. Bower
    E. S. Newlands
    N. M. Bleehen
    M. Brada
    R. J. H. Begent
    H. Calvert
    I. Colquhoun
    P. Lewis
    M. H. Brampton
    [J]. Cancer Chemotherapy and Pharmacology, 1997, 40 : 484 - 488
  • [10] Phase II study of sunitinib and irinotecan in patients with recurrent high-grade glioma (HGG).
    Grisanti, S.
    Pedersini, R.
    Ferrari, V. D.
    Liserre, R.
    Consoli, F.
    Poliani, L.
    Boglione, M.
    Rangoni, G.
    Montini, E.
    Simoncini, E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345